- Republicans and Democrats on Capitol Hill might find common ground on some smaller — but important — issues, such as restricting surprise medical bills, which consumers get after they receive care from doctors outside their insurance network. But changes in the GOP committee chairs could dim current efforts to reduce prescription drug prices.
- One issue that might have bipartisan support next year is enhancement of the public health system. The coronavirus pandemic has shown that parts of the system have deteriorated in recent years.
- Democrats’ dreams of major gains in both the House and Senate failed to materialize Tuesday. That suggests that their arguments that Democrats would protect the ACA did not carry as much weight this year as they did in 2018, when the party saw success in midterm elections.
- Although the campaign is over, there’s no clear indication that the debate on how to attack COVID-19 will become less politicized. The fear of another economic shutdown and the consequences of that for millions of Americans is driving strong — and very divided — public sentiment on the issue.
- The Trump administration appeared to be seeking to enhance the president’s campaign in Georgia when it announced Sunday that it would allow the state to starkly revamp its offerings of ACA marketplace plans in a couple of years.
- Share on X (Opens in new window) X
- Share on Facebook (Opens in new window) Facebook
- Share on LinkedIn (Opens in new window) LinkedIn
- Email a link to a friend (Opens in new window) Email
- Print (Opens in new window) Print
Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact NewsWeb@kff.org.